Epimedium treatment significantly inhibited the expression of IL-1β, TNF-α, and IL-6 and enhanced the expression of IL-4, which suggests that Epimedium exerted its neuroprotective effects via regulating the expression of proinflammatory and anti-inflammatory cytokine following ischemic stroke. Here, IL4 is linked to ischemic stroke.